Aligos Therapeutics Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections. | ![]() Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. | |
Founding Date | Founding Date 2018 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Leuven, BE | Locations Cambridge, US HQ |
Employees | Employees 706% increase | Employees 43223% increase |
Valuation ($) | Valuation ($) 28.8 m | Valuation ($) 202.2 m |
Financial | ||
Net income | Net income ($24.2m) (FY, 2025) | Net income ($74.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 225m | Total funding raised $ 55m |

We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View company